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Mutations in phosphodiesterase 6 identified in familial cases
of retinitis pigmentosa
Inayat Ullah1, Firoz Kabir2, Clare Brooks S Gottsch2, Muhammad Asif Naeem1, Aditya A Guru3, Radha Ayyagari3, Shaheen N Khan1,
Sheikh Riazuddin1,4,5, Javed Akram4,5 and S Amer Riazuddin2,6
To delineate the genetic determinants associated with retinitis pigmentosa (RP), a hereditary retinal disorder, we recruited four
large families manifesting cardinal symptoms of RP. We localized these families to regions on the human genome harboring the α
and β subunits of phosphodiesterase 6 and identified mutations that were absent in control chromosomes. Our data suggest that
mutations in PDE6A and PDE6B are responsible for the retinal phenotype in these families.
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The diagnosis of retinitis pigmentosa (RP) encompasses a group
of hereditary retinal disorders characterized by progressive
degeneration of rod photoreceptors followed by the degeneration
of cone photoreceptors. The initial loss of rod cells causes night
blindness and constricts the visual field, while the subsequent loss
of cone cells results in a total loss of vision.1 Though it affects one
in 4,000, RP is clinically variable, so it is not surprising that it has
been found to be genetically heterogeneous as well.2,3 Clinical
manifestation of the disease includes pigmentary deposits in the
retina, waxy disc pallor and attenuation of retinal blood vessels.1
In addition, affected individuals often have severely abnormal or
undetectable electroretinographic responses, even in the early
stage of the disease.1
RP is a genetically heterogeneous disorder that manifests as an
autosomal dominant, autosomal recessive and X-linked trait.
Phosphodiesterase 6 (PDE6) is one of the critical enzymes of
the visual phototransduction cascade that facilitates the hydrolysis
of cyclic guanine monophosphate, a reaction that maintains
physiological levels of cyclic guanine monophosphate in the
vertebrate retina. The PDE6 enzyme is composed of two catalytic
subunits, PDE6A (88 kDa) and PDE6B (84 kDa), and a regulatory/
inhibitory subunit, PDE6G (11 kDa).4 Reports on the pathogenesis
of RP have previously implicated mutations in genes encoding
PDE6A (OMIM: 180071) and PDE6B (OMIM: 180072)
(Supplementary Tables S5 and S6).
In the pursuit of determining the genetic basis of autosomal
recessive RP, we have collected a large cohort of volunteer
participants from highly inbred families, all affected by retinal
dystrophies. We previously reported causal mutations in PDE6A
and PDE6B in multiple families that accounted for 2–3% of our
large cohort, suggesting that mutations in these subunits of PDE6
are a significant contributor to the genetic load of autosomal
recessive RP in the Pakistani population.5–7 Over the past 5 years,
we have recruited additional familial cases of autosomal recessive
RP, bringing the total number of our cohort to 4350 families.
Here we report novel mutations identified by our ongoing
research.
The four families reported in this study were recruited from the
Punjab province of Pakistan (Figure 1). Approval was granted from
the Institutional Review Boards of the National Centre of
Excellence in Molecular Biology in Lahore, Pakistan, the National
Eye Institute in Bethesda, MD, USA, and Johns Hopkins University
in Baltimore, MD, USA. Each individual participating in this study
was informed and provided written consent in accordance with
the Declaration of Helsinki. A detailed medical history was
obtained by interviewing family members. Color vision was
assessed with Ishihara charts. Fundoscopy was performed at the
Layton Rehmatulla Benevolent Trust Hospital (Lahore,
Pakistan). Electroretinographic measurements were recorded
with equipment manufactured by LKC (Gaithersburg, MD, USA).
Dark-adapted rod responses were measured with incident flash
attenuated by − 25 dB, whereas rod-cone responses were
measured at 0 dB. The 30 Hz flicker responses were recorded at
0 dB with a background illumination of 17–34 cd/m2.
Each affected member of the participating families was
thoroughly evaluated to confirm that their ophthalmological
symptoms were caused by RP (Supplementary Table S1). In early
childhood, affected patients exhibited night blindness, a common
indicator of RP. Fundus examinations documented arteriolar
constriction, waxy pallor of the optic disc and pigmentation on
the peripheral and central retina—all cardinal symptoms of
RP that substantiated diagnoses of the affected subjects
(Supplementary Figure S1). Furthermore, both rod and cone
responses were absent when measured by electroretinography;
scotopic and photopic electroretinographic responses were highly
reduced or absent (Figure 2).
The genomic DNA used in all experiments was extracted from
the white blood cells of whole-blood samples with a modified
procedure as described.8 We measured the concentration of the
DNA with a SmartSpec Plus Spectrophotometer (Bio-Rad, Hercules,
CA, USA). Short tandem repeat markers spanning either PDE6A or
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PDE6B were selected to perform exclusion analysis. We used Gene
Mapper software (Applied Biosystems, Foster City, CA, USA) to
assign genotypes and performed linkage analysis with alleles
identified by exclusion analysis.
These analyses localized PKRP264 and PKRP336 to the PDE6B
locus on chromosome 4p and PKRP345 and PKRP360 to the PDE6A
locus on chromosome 5q. Maximum two-point logarithm of odds
(LOD) scores of 2.04 and 3.10 were obtained with the alleles
D4S2936 and D4S3038, respectively, at θ=0 for PKRP264, and
scores of 3.04, 2.88 and 1.86 were obtained with D4S2936, D4S3038
and D4S1614, respectively, at θ=0 for PKRP336 (Supplementary
Table S2). Likewise, LOD scores of 1.79, 2.02 and 1.21 were obtained
with the alleles D5S2015, D5S2013 and D5S1469, respectively, at
θ=0 for PKRP345, and scores of 2.33, 2.79, 2.21 and 1.42 were
obtained with D5S812, D5S2015, D5S2013 and D5S1469, respec-
tively, at θ=0 for PKRP360 (Supplementary Table S2).
Next we sequenced all coding exons, exon–intron boundaries
and the 5′ and 3′ untranslated regions of PDE6B for PKRP264
and PKRP336 and PDE6A for PKRP345 and PKRP360. Primer pairs
for individual exons of PDE6A and PDE6B were designed
using Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/). The
primer sequences and annealing temperatures are provided in
Supplementary Tables S3 and S4. Sequencing reactions were
completed as described,6,7 and sequencing results were
Figure 1. Pedigree drawings with haplotypes formed from alleles of chromosome 4p and 5q microsatellite markers. (a) PKRP264, (b) PKRP336,
(c) PKRP345 and (d) PKRP360. Alleles constituting the risk haplotype (segregating with the retinitis pigmentosa (RP) phenotype) are shaded
black, whereas alleles not segregating with RP are shown in white. Square: male; circle: female; filled symbol: affected individual; double line
between symbols: consanguineous mating; diagonal line through symbol: deceased individual.
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assembled with the ABI PRISM sequencing analysis software,
version 3.7, and analyzed with SeqScape software (Applied
Biosystems).
Sanger sequencing identified novel deletion mutations in
PDE6B: c.243delG (p.R82Afs68*) and c.12_15delTGAG (p.S4Rfs23*)
in PKRP264 and PKRP336, respectively (Supplementary Figures S2
and S3). Likewise, previously reported nonsense and missense
mutations were identified in PDE6A: c.769C4T (p.R257*) and
c.304C4A (p.R102S) in PKRP345 and PKRP360, respectively
(Supplementary Figures S4 and S5). All mutations segregated
with the disease phenotype in their respective families and
were absent from ethnically matched control chromosomes.
Additionally, these variants were not present in the NHLBI exome
variant server, 1000 Genomes or the dbSNP database.
Next we evaluated the evolutionary conservation of R102 in
other PDE6A orthologs, which illustrated that the amino-acid
residue R102 is highly conserved (data not shown). We next
examined the possible impact on the PDE6A protein with the SIFT
Figure 2. Electroretinographic recordings of individuals diagnosed with retinitis pigmentosa. Panels (from left to right) are combined rod and
cone response and cone flicker response of oculus dexter (OD) and oculus sinister (OS). (a) Affected individual 17 and (b) affected individual
18 of PKRP345, (c) affected individual 9, (d) affected individual 10, (e) affected individual 11, (f) affected individual 12 and (g) unaffected
control individual 14 of PKRP264. Affected individuals exhibit no detectable electroretinographic responses, whereas the unaffected
individual exhibits normal a- and b-waves, indicating normal rod and cone function.
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and PolyPhen-2 algorithms. SIFT prediction suggested that the
R102S substitution would not be tolerated by the native three-
dimensional structure of PDE6A. Likewise, position-specific score
differences obtained from PolyPhen-2 suggested that the R102S
substitution would be probably damaging, with a score of 0.993
(sensitivity: 0.70; specificity: 0.97).
In conclusion, we report four causal mutations present in
consanguineous RP families recruited from the Punjab province of
Pakistan. PDE6 is necessary for regulating the concentrations of
cyclic guanine monophosphate in the retina and mutations in its
subunits have been associated with RP, including a pathogenic
connection between PDE6B and congenital stationary night
blindness. We have previously reported mutations in both PDE6A
and PDE6B that are responsible for RP in our cohort of Pakistani
families.5–7 We have recruited 4350 families, and of these, we
have now localized 11 familial cases to PDE6 genes (PDE6A and
PDE6B), suggesting that they contribute approximately 3% of the
total genetic load of autosomal recessive RP in our cohort.
Determining the genetic cause of RP contributes to our under-
standing of the disease itself and of the normal physiological
function of the retina. A better understanding of the physiology
and its underlying pathology will hopefully lead to improved
diagnosis and treatment of RP.
HGV DATABASE
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